KalVista Pharmaceuticals, Inc.KALVNASDAQ
Loading
Interest Income Over TimeExpanding
Percentile Rank100
3Y CAGR+47.1%
5Y CAGR+51.1%
Year-over-Year Change
Income earned from interest-bearing assets
3Y CAGR
+47.1%/yr
vs +12.4%/yr prior
5Y CAGR
+51.1%/yr
Recent deceleration
Acceleration
+34.7pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
7.9x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $7.11M | +10.5% |
| 2025 | $6.43M | - |
| 2024 | $0.00 | -100.0% |
| 2023 | $2.23M | +104.8% |
| 2022 | $1.09M | +20.7% |
| 2021 | $903000.00 | -50.7% |
| 2020 | $1.83M | +31.0% |
| 2019 | $1.40M | +1603.7% |
| 2018 | $82000.00 | +127.8% |
| 2017 | $36000.00 | - |